The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

With this ruling, Avadel can seek and be granted FDA approval for LUMRYZ in Idiopathic Hypersomnia - - Federal Circuit decision permits new clinical trials and further development of LUMRYZ™ for the ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company’s Chief Financial ...

Vertex Pharmaceuticals (VRTX) and Neurocrine Biosciences (NBIX) shares are moving sharply after their respective earnings ...

Board Member Dr. Karen Smith to serve as Interim Chief Medical OfficerPHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context ...

BOULDER, Colo., May 06, 2025 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical ...

Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven biopharmaceutical company, announced today the appointment of Laura Réveillon, PhD as EVP, Strategy & Transformation, ...

NRx Pharma files patent application for NRX-100, its proprietary, preservative free formulation of IV ketamine: Wilmington, Delaware Tuesday, May 6, 2025, 17:00 Hrs [IST] NRx Phar ...

The MOU aims to collaborate on enhancing public health services, awareness programs, and advancing disease management through ...

TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is deepening its collaboration with ...

ANN ARBOR, Mich. (AP) — ANN ARBOR, Mich. (AP) — Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $40.5 million in its first quarter. On a per-share basis, the Ann Arbor, Michigan-based ...

Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the ...